Biotechnology Assets Statistics
Total Valuation
Biotechnology Assets has a market cap or net worth of EUR 19.76 million. The enterprise value is 23.33 million.
Market Cap | 19.76M |
Enterprise Value | 23.33M |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Biotechnology Assets has 63.74 million shares outstanding.
Shares Outstanding | 63.74M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.11% |
Float | 35.78M |
Valuation Ratios
The trailing PE ratio is 11.37.
PE Ratio | 11.37 |
Forward PE | n/a |
PS Ratio | 4.58 |
PB Ratio | 2.68 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.27, with an EV/FCF ratio of -1,067.89.
EV / Earnings | 14.82 |
EV / Sales | 5.97 |
EV / EBITDA | 6.27 |
EV / EBIT | 8.61 |
EV / FCF | -1,067.89 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 63.31.
Current Ratio | 1.04 |
Quick Ratio | 1.04 |
Debt / Equity | 63.31 |
Debt / EBITDA | 1.11 |
Debt / FCF | -189.33 |
Interest Coverage | 8.71 |
Financial Efficiency
Return on equity (ROE) is 30.25% and return on invested capital (ROIC) is 14.85%.
Return on Equity (ROE) | 30.25% |
Return on Assets (ROA) | 9.65% |
Return on Capital (ROIC) | 14.85% |
Revenue Per Employee | 105,633 |
Profits Per Employee | 42,534 |
Employee Count | 37 |
Asset Turnover | 0.22 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +97.91% in the last 52 weeks. The beta is 1.39, so Biotechnology Assets's price volatility has been higher than the market average.
Beta (5Y) | 1.39 |
52-Week Price Change | +97.91% |
50-Day Moving Average | 0.32 |
200-Day Moving Average | 0.37 |
Relative Strength Index (RSI) | 49.85 |
Average Volume (20 Days) | 27,594 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biotechnology Assets had revenue of EUR 3.91 million and earned 1.57 million in profits. Earnings per share was 0.03.
Revenue | 3.91M |
Gross Profit | 3.46M |
Operating Income | 2.71M |
Pretax Income | 2.32M |
Net Income | 1.57M |
EBITDA | 3.72M |
EBIT | 2.71M |
Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 416,868 in cash and 4.14 million in debt, giving a net cash position of -3.72 million or -0.06 per share.
Cash & Cash Equivalents | 416,868 |
Total Debt | 4.14M |
Net Cash | -3.72M |
Net Cash Per Share | -0.06 |
Equity (Book Value) | 6.53M |
Book Value Per Share | 0.12 |
Working Capital | 147,778 |
Cash Flow
In the last 12 months, operating cash flow was 47,734 and capital expenditures -69,577, giving a free cash flow of -21,843.
Operating Cash Flow | 47,734 |
Capital Expenditures | -69,577 |
Free Cash Flow | -21,843 |
FCF Per Share | -0.00 |
Margins
Gross margin is 88.47%, with operating and profit margins of 69.28% and 40.27%.
Gross Margin | 88.47% |
Operating Margin | 69.28% |
Pretax Margin | 59.42% |
Profit Margin | 40.27% |
EBITDA Margin | 95.23% |
EBIT Margin | 69.28% |
FCF Margin | -0.56% |
Dividends & Yields
Biotechnology Assets does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 8.79% |
FCF Yield | -0.11% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |